Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors

Günter Emons*, Manfred Kaufmann, Grigor Gorchev, Valentina Tsekova, Carsten Gründker, Andreas R. Günthert, Lars C. Hanker, Maya Velikova, Herbert Sindermann, Jürgen Engel, Andrew V. Schally

*Corresponding author for this work
46 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science